US Stock MarketDetailed Quotes

RARE Ultragenyx Pharmaceutical

Watchlist
  • 42.370
  • -1.010-2.33%
Close Apr 19 16:00 ET
  • 42.370
  • 0.0000.00%
Post 16:52 ET
3.49BMarket Cap-5135P/E (TTM)

Ultragenyx Pharmaceutical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
19.52%434.25M
23.27%127.39M
8.10%98.05M
21.23%108.31M
25.72%100.5M
3.39%363.33M
23.93%103.35M
11.09%90.7M
2.72%89.34M
-19.58%79.94M
Operating revenue
19.52%434.25M
23.27%127.39M
8.10%98.05M
21.23%108.31M
25.72%100.5M
3.39%363.33M
23.93%103.35M
11.09%90.7M
2.72%89.34M
-19.58%79.94M
Cost of revenue
59.64%45.21M
126.57%12.05M
27.30%10.99M
19.88%9.91M
100.93%12.26M
76.91%28.32M
51.58%5.32M
106.73%8.63M
163.71%8.27M
17.58%6.1M
Gross profit
16.13%389.04M
17.66%115.34M
6.08%87.07M
21.37%98.4M
19.51%88.24M
-0.12%335.01M
22.72%98.03M
5.94%82.07M
-3.30%81.07M
-21.62%73.84M
Operating expense
-2.61%958.25M
-2.57%237.39M
-24.41%232.16M
10.64%246.35M
15.15%242.34M
37.20%983.93M
33.55%243.66M
83.59%307.14M
33.64%222.67M
4.83%210.47M
Selling and administrative expenses
11.38%309.8M
5.47%76.83M
7.27%74.92M
19.47%81.4M
13.87%76.65M
26.44%278.14M
22.58%72.85M
29.62%69.84M
27.57%68.14M
26.39%67.31M
Research and development costs
-8.12%648.45M
-6.00%160.56M
-33.73%157.25M
6.74%164.95M
15.75%165.7M
41.97%705.79M
38.85%170.81M
109.23%237.3M
36.50%154.53M
-2.96%143.16M
Operating profit
12.28%-569.21M
16.19%-122.05M
35.53%-145.1M
-4.49%-147.96M
-12.79%-154.11M
-69.99%-648.92M
-41.99%-145.63M
-150.55%-225.07M
-71.06%-141.59M
-28.21%-136.63M
Net non-operating interest income expense
-23.09%-39.32M
9.31%-8.78M
-6.91%-11.78M
-82.63%-9.41M
-53.46%-9.35M
-16.17%-31.94M
-187.63%-9.68M
-33.20%-11.02M
36.19%-5.15M
21.71%-6.09M
Non-operating interest income
141.00%26.69M
38.00%8.55M
68.85%5.88M
563.40%5.96M
1,173.28%6.29M
474.38%11.07M
1,308.64%6.2M
753.68%3.48M
103.85%899K
-22.69%494K
Non-operating interest expense
53.44%66M
9.16%17.33M
21.79%17.67M
154.05%15.38M
137.48%15.64M
46.20%43.02M
317.30%15.87M
67.05%14.51M
-28.94%6.05M
-21.79%6.58M
Other net income (expense)
100.29%60K
94.65%3.93M
22.45%-2.12M
84.45%-1.73M
99.71%-26K
52.31%-20.87M
112.24%2.02M
-110.80%-2.73M
64.28%-11.11M
57.78%-9.04M
Gain on sale of security
102.06%397K
2.66%1.89M
12.73%-1.42M
102.56%261K
96.42%-334K
54.12%-19.3M
111.43%1.84M
-106.33%-1.63M
67.20%-10.18M
54.76%-9.33M
Other non- operating income (expenses)
78.48%-337K
1,035.00%2.04M
36.74%-699K
-113.87%-1.99M
6.57%308K
7.17%-1.57M
143.90%180K
-166.27%-1.11M
-1,288.06%-930K
136.35%289K
Income before tax
13.29%-608.46M
17.22%-126.89M
33.42%-159M
-0.78%-159.1M
-7.72%-163.48M
-54.91%-701.73M
-25.19%-153.28M
-227.98%-238.82M
-29.43%-157.86M
-11.79%-151.76M
Income tax
-132.04%-1.83M
-155.13%-3.7M
-89.66%650K
142.38%732K
-11.29%495K
445.59%5.7M
-7,355.00%-1.45M
3,354.40%6.29M
-34.77%302K
47.23%558K
Net income
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
-29.19%-158.16M
-11.88%-152.32M
Net income continuous Operations
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
-29.19%-158.16M
-11.88%-152.32M
Minority interest income
Net income attributable to the parent company
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
-29.19%-158.16M
-11.88%-152.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
14.25%-606.64M
18.86%-123.19M
34.87%-159.65M
-1.05%-159.83M
-7.65%-163.97M
-55.81%-707.42M
-23.99%-151.83M
-235.77%-245.11M
-29.19%-158.16M
-11.88%-152.32M
Basic earnings per share
18.48%-8.25
29.63%-1.52
36.29%-2.23
0.44%-2.25
-6.39%-2.33
-51.04%-10.12
-20.67%-2.16
-224.07%-3.5
-24.86%-2.26
-7.88%-2.19
Diluted earnings per share
18.48%-8.25
29.63%-1.52
36.29%-2.23
0.44%-2.25
-6.39%-2.33
-51.04%-10.12
-20.67%-2.16
-224.07%-3.5
-24.86%-2.26
-7.88%-2.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 19.52%434.25M23.27%127.39M8.10%98.05M21.23%108.31M25.72%100.5M3.39%363.33M23.93%103.35M11.09%90.7M2.72%89.34M-19.58%79.94M
Operating revenue 19.52%434.25M23.27%127.39M8.10%98.05M21.23%108.31M25.72%100.5M3.39%363.33M23.93%103.35M11.09%90.7M2.72%89.34M-19.58%79.94M
Cost of revenue 59.64%45.21M126.57%12.05M27.30%10.99M19.88%9.91M100.93%12.26M76.91%28.32M51.58%5.32M106.73%8.63M163.71%8.27M17.58%6.1M
Gross profit 16.13%389.04M17.66%115.34M6.08%87.07M21.37%98.4M19.51%88.24M-0.12%335.01M22.72%98.03M5.94%82.07M-3.30%81.07M-21.62%73.84M
Operating expense -2.61%958.25M-2.57%237.39M-24.41%232.16M10.64%246.35M15.15%242.34M37.20%983.93M33.55%243.66M83.59%307.14M33.64%222.67M4.83%210.47M
Selling and administrative expenses 11.38%309.8M5.47%76.83M7.27%74.92M19.47%81.4M13.87%76.65M26.44%278.14M22.58%72.85M29.62%69.84M27.57%68.14M26.39%67.31M
Research and development costs -8.12%648.45M-6.00%160.56M-33.73%157.25M6.74%164.95M15.75%165.7M41.97%705.79M38.85%170.81M109.23%237.3M36.50%154.53M-2.96%143.16M
Operating profit 12.28%-569.21M16.19%-122.05M35.53%-145.1M-4.49%-147.96M-12.79%-154.11M-69.99%-648.92M-41.99%-145.63M-150.55%-225.07M-71.06%-141.59M-28.21%-136.63M
Net non-operating interest income expense -23.09%-39.32M9.31%-8.78M-6.91%-11.78M-82.63%-9.41M-53.46%-9.35M-16.17%-31.94M-187.63%-9.68M-33.20%-11.02M36.19%-5.15M21.71%-6.09M
Non-operating interest income 141.00%26.69M38.00%8.55M68.85%5.88M563.40%5.96M1,173.28%6.29M474.38%11.07M1,308.64%6.2M753.68%3.48M103.85%899K-22.69%494K
Non-operating interest expense 53.44%66M9.16%17.33M21.79%17.67M154.05%15.38M137.48%15.64M46.20%43.02M317.30%15.87M67.05%14.51M-28.94%6.05M-21.79%6.58M
Other net income (expense) 100.29%60K94.65%3.93M22.45%-2.12M84.45%-1.73M99.71%-26K52.31%-20.87M112.24%2.02M-110.80%-2.73M64.28%-11.11M57.78%-9.04M
Gain on sale of security 102.06%397K2.66%1.89M12.73%-1.42M102.56%261K96.42%-334K54.12%-19.3M111.43%1.84M-106.33%-1.63M67.20%-10.18M54.76%-9.33M
Other non- operating income (expenses) 78.48%-337K1,035.00%2.04M36.74%-699K-113.87%-1.99M6.57%308K7.17%-1.57M143.90%180K-166.27%-1.11M-1,288.06%-930K136.35%289K
Income before tax 13.29%-608.46M17.22%-126.89M33.42%-159M-0.78%-159.1M-7.72%-163.48M-54.91%-701.73M-25.19%-153.28M-227.98%-238.82M-29.43%-157.86M-11.79%-151.76M
Income tax -132.04%-1.83M-155.13%-3.7M-89.66%650K142.38%732K-11.29%495K445.59%5.7M-7,355.00%-1.45M3,354.40%6.29M-34.77%302K47.23%558K
Net income 14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M-29.19%-158.16M-11.88%-152.32M
Net income continuous Operations 14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M-29.19%-158.16M-11.88%-152.32M
Minority interest income
Net income attributable to the parent company 14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M-29.19%-158.16M-11.88%-152.32M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 14.25%-606.64M18.86%-123.19M34.87%-159.65M-1.05%-159.83M-7.65%-163.97M-55.81%-707.42M-23.99%-151.83M-235.77%-245.11M-29.19%-158.16M-11.88%-152.32M
Basic earnings per share 18.48%-8.2529.63%-1.5236.29%-2.230.44%-2.25-6.39%-2.33-51.04%-10.12-20.67%-2.16-224.07%-3.5-24.86%-2.26-7.88%-2.19
Diluted earnings per share 18.48%-8.2529.63%-1.5236.29%-2.230.44%-2.25-6.39%-2.33-51.04%-10.12-20.67%-2.16-224.07%-3.5-24.86%-2.26-7.88%-2.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg